Abstract
A 27-year-old primigravid woman with advanced preterm labour at 23 weeks and 5 days gestation received tocolytic therapy with a continuous infusion of the oxytocin antagonist, atosiban, during 154 h. The delivery was postponed for 12 days. The baby was discharged after 3 months of neonatal care and at 6 months of age is healthy. The prolonged treatment was not associated with maternal or fetal side effects.
MeSH terms
-
Adult
-
Anti-Bacterial Agents / administration & dosage
-
C-Reactive Protein / analysis
-
Cefuroxime / administration & dosage
-
Cervix Uteri / microbiology
-
Female
-
Gestational Age*
-
Humans
-
Infusions, Intravenous
-
Male
-
Metronidazole / administration & dosage
-
Obstetric Labor, Premature / drug therapy*
-
Oxytocin / antagonists & inhibitors*
-
Pregnancy
-
Streptococcus agalactiae
-
Terbutaline / administration & dosage
-
Terbutaline / adverse effects
-
Vasotocin / administration & dosage*
-
Vasotocin / analogs & derivatives*
Substances
-
Anti-Bacterial Agents
-
atosiban
-
Metronidazole
-
Oxytocin
-
C-Reactive Protein
-
Terbutaline
-
Cefuroxime
-
Vasotocin